GET 10% OFF FIRST ORDER

FREE SHIPPING OVER $55

USA CUSTOMERS — SHOP DUTY FREE

Your cart

Your cart is empty

Continue shopping
Multi probiotics 40 billion CFU 11 strains supplement capsules
Probiotics 40 billion CFU 11 strains gut flora support supplement
Probiotics 40 billion CFU supplement facts label 11 strains
Multi probiotics 40 billion CFU 11 strains supplement capsules

Eleven-strain synbiotic probiotic formula delivering a minimum of 40 Billion CFU per serving (2 capsules), guaranteed at the expiry date not just at manufacture. Six Lactobacillus and five Bifidobacterium strains with FOS prebiotic. Helps support a healthy gut flora. Helps reduce the frequency of colds. Helps relieve gastrointestinal symptoms associated with antibiotic use.

Why This Formula?

Most probiotics state their CFU at the time of manufacture a number that declines significantly before you open the bottle. This formula guarantees a minimum of 40 Billion CFU at the expiry date, manufactured with 66 Billion CFU minimum per serving (a 65% overage) to ensure the guarantee holds throughout full shelf life. Eleven strains. FOS prebiotic included. One synbiotic capsule.

The 11 Strains

Lactobacillus 6 strains | 23 Billion CFU

  • Lactobacillus casei (HA-108) — 7.0 Billion CFU
  • Lactobacillus rhamnosus (HA-111) — 7.0 Billion CFU | one of the most researched probiotic species for GI support and antibiotic recovery
  • Lactobacillus paracasei (HA-196) — 4.0 Billion CFU
  • Lactobacillus acidophilus (HA-122) — 2.0 Billion CFU
  • Lactobacillus plantarum (HA-119) — 2.0 Billion CFU
  • Lactobacillus fermentum (HA-179) — 2.0 Billion CFU

Bifidobacterium — 5 strains | 17 Billion CFU

  • Bifidobacterium breve (HA-129) — 5.0 Billion CFU
  • Bifidobacterium longum (HA-135) — 5.0 Billion CFU | one of the most abundant Bifidobacterium species in the adult human gut
  • Bifidobacterium bifidum (HA-132) — 3.0 Billion CFU
  • Bifidobacterium animalis (HA-194) — 2.0 Billion CFU | noted for resilience and survival through GI transit
  • Lactobacillus salivarius (HA-118) — 2.0 Billion CFU

FOS Prebiotic (Fructooligosaccharide)
A short-chain carbohydrate naturally found in chicory root, garlic, and onion. Passes intact to the large intestine where it is selectively fermented by Lactobacillus and Bifidobacterium the same genera in this formula providing a preferred substrate to support their survival and activity. A formula combining probiotics and a prebiotic is called a synbiotic.

Multi Probiotics 40 Billion CFU | 11 Strains | Gut Flora Support | 60 Vcaps

$29.50
4.8 (4)

Health Canada Licensed Natural Health Product (NPN 80071438)

Auto-renews, skip or cancel anytime.

To add to cart, go to the product page and select a purchase option
Shipping calculated at checkout.

Eleven-strain synbiotic probiotic formula delivering a minimum of 40 Billion CFU per serving (2 capsules), guaranteed at the expiry date not just at manufacture. Six Lactobacillus and five Bifidobacterium strains with FOS prebiotic. Helps support a healthy gut flora. Helps reduce the frequency of colds. Helps relieve gastrointestinal symptoms associated with antibiotic use.

Why This Formula?

Most probiotics state their CFU at the time of manufacture a number that declines significantly before you open the bottle. This formula guarantees a minimum of 40 Billion CFU at the expiry date, manufactured with 66 Billion CFU minimum per serving (a 65% overage) to ensure the guarantee holds throughout full shelf life. Eleven strains. FOS prebiotic included. One synbiotic capsule.

The 11 Strains

Lactobacillus 6 strains | 23 Billion CFU

  • Lactobacillus casei (HA-108) — 7.0 Billion CFU
  • Lactobacillus rhamnosus (HA-111) — 7.0 Billion CFU | one of the most researched probiotic species for GI support and antibiotic recovery
  • Lactobacillus paracasei (HA-196) — 4.0 Billion CFU
  • Lactobacillus acidophilus (HA-122) — 2.0 Billion CFU
  • Lactobacillus plantarum (HA-119) — 2.0 Billion CFU
  • Lactobacillus fermentum (HA-179) — 2.0 Billion CFU

Bifidobacterium — 5 strains | 17 Billion CFU

  • Bifidobacterium breve (HA-129) — 5.0 Billion CFU
  • Bifidobacterium longum (HA-135) — 5.0 Billion CFU | one of the most abundant Bifidobacterium species in the adult human gut
  • Bifidobacterium bifidum (HA-132) — 3.0 Billion CFU
  • Bifidobacterium animalis (HA-194) — 2.0 Billion CFU | noted for resilience and survival through GI transit
  • Lactobacillus salivarius (HA-118) — 2.0 Billion CFU

FOS Prebiotic (Fructooligosaccharide)
A short-chain carbohydrate naturally found in chicory root, garlic, and onion. Passes intact to the large intestine where it is selectively fermented by Lactobacillus and Bifidobacterium the same genera in this formula providing a preferred substrate to support their survival and activity. A formula combining probiotics and a prebiotic is called a synbiotic.

Supplement Facts

Supplement Facts

Serving Size: 2 Capsules

Servings Per Container: 30

Ingredient
Amount Per
Serving
% Daily
Value
Lactobacillus casei (HA-108)
7.0 Billion CFU
†
Lactobacillus rhamnosus (HA-111)
7.0 Billion CFU
†
Bifidobacterium breve (HA-129)
5.0 Billion CFU
†
Bifidobacterium longum (HA-135)
5.0 Billion CFU
†
Lactobacillus paracasei (HA-196)
4.0 Billion CFU
†
Bifidobacterium bifidum (HA-132)
3.0 Billion CFU
†
Lactobacillus acidophilus (HA-122)
2.0 Billion CFU
†
Bifidobacterium animalis (HA-194)
2.0 Billion CFU
†
Lactobacillus plantarum (HA-119)
2.0 Billion CFU
†
Lactobacillus fermentum (HA-179)
2.0 Billion CFU
†
Lactobacillus salivarius (HA-118)
2.0 Billion CFU
†

† Daily Value not established

Other Ingredients:
Fructooligosaccharide (FOS), Silica, Hypromellose (Vegetable Capsule Shell).

Clinical Research

Lactobacillus rhamnosus GG for prevention of antibiotic associated diarrhea: a systematic review and meta analysis

Journal of Infection, 2012

This systematic review and meta analysis evaluated randomized controlled trials examining the efficacy of Lactobacillus rhamnosus for the prevention of antibiotic associated diarrhea (AAD) in adults and children. L. rhamnosus is one of the most extensively studied probiotic species in the context of antibiotic associated gastrointestinal symptoms, with a well characterized mechanism of action involving competitive exclusion of pathogenic bacteria, production of bacteriocins, and reinforcement of intestinal barrier integrity. The meta analysis found that L. rhamnosus supplementation was associated with a statistically significant reduction in the incidence of antibiotic associated diarrhea compared to placebo across multiple included trials. The authors noted that L. rhamnosus demonstrated a favorable safety profile and was well tolerated in all included populations.

Bifidobacterium longum and Bifidobacterium breve supplementation for gut microbiota modulation in healthy adults: a randomized, double blind, placebo controlled trial

Beneficial Microbes, 2019

This randomized, double blind, placebo controlled trial examined the effects of Bifidobacterium longum and Bifidobacterium breve supplementation on gut microbiota composition and markers of gut flora balance in healthy adults over a 4 week intervention period. Bifidobacterium species are among the most clinically important beneficial bacteria in the human large intestine, where they ferment dietary fibers and prebiotics to produce short chain fatty acids the primary energy source for colonocytes (colon lining cells). Participants receiving the Bifidobacterium combination demonstrated significant increases in fecal Bifidobacterium counts and improvements in gut flora diversity scores compared to placebo. The authors noted that B. longum is one of the most abundant Bifidobacterium species in the healthy adult human gut, and that B. breve demonstrates strong colonization characteristics.

Probiotics for preventing acute upper respiratory tract infections: a Cochrane systematic review

Cochrane Database of Systematic Reviews, 2015

This Cochrane systematic review and meta analysis evaluated randomized controlled trials on the use of probiotic supplementation for the prevention of acute upper respiratory tract infections (URTIs), including the common cold, in adults and children. The review included trials examining Lactobacillus and Bifidobacterium strains across multiple study populations and durations. Probiotic supplementation was associated with a statistically significant reduction in the number of participants experiencing acute URTIs and a reduction in the mean duration of episodes compared to placebo. The proposed mechanisms include immunomodulatory effects of probiotic bacteria on mucosal immunity and systemic immune response including modulation of secretory IgA production and natural killer cell activity. The review concluded that probiotics were superior to placebo for reducing the frequency of acute upper respiratory tract infections, with a favorable safety profile.

Research information is provided for educational purposes and does not replace the product's approved label information.

Frequently Asked Questions

What is Multi Probiotics 40 Billion CFU?

Multi Probiotics 40 Billion CFU is a multi strain probiotic supplement formulated to help support a healthy balance of intestinal bacteria and overall digestive wellness.

What are the 11 probiotic strains and what does each contribute?

Multi Probiotics 40 Billion CFU contains 6 Lactobacillus strains and 5 Bifidobacterium strains per serving (2 capsules), totalling a minimum of 40 Billion CFU at expiry. Lactobacillus strains (23 Billion CFU total): L. casei HA-108 (7.0B), L. rhamnosus HA-111 (7.0B one of the most researched probiotic species for gastrointestinal support and recovery from antibiotic-associated GI symptoms), L. paracasei HA-196 (4.0B), L. acidophilus HA-122 (2.0B), L. plantarum HA-119 (2.0B), L. fermentum HA-179 (2.0B). Bifidobacterium strains (17 Billion CFU total): B. breve HA-129 (5.0B), B. longum HA-135 (5.0B one of the most abundant Bifidobacterium species in the adult human gut), B. bifidum HA-132 (3.0B), B. animalis HA-194 (2.0B noted for resilience and survival through GI transit), L. salivarius HA-118 (2.0B). Bifidobacterium strains make up approximately 42% of the total CFU a large intestine focused composition.

What are the benefits of taking probiotics?

Probiotics can help support digestive health, intestinal flora balance, and normal gastrointestinal function by supplying beneficial microorganisms to the gut.

What does gut flora support mean?

Gut flora refers to the community of microorganisms naturally living in the digestive tract. Probiotics help maintain a healthy balance of beneficial intestinal bacteria.

How long does it take for probiotics to work?

The response to probiotics varies between individuals. Some people may notice digestive changes relatively quickly, while maintaining a balanced gut microbiome may require consistent use over time

Canadian-Made

Lab-Tested

Health Canada Approved

20 Years of Research

Related Product

Recently viewed